HK1112235A1 - Indoline compounds - Google Patents

Indoline compounds

Info

Publication number
HK1112235A1
HK1112235A1 HK08107399.4A HK08107399A HK1112235A1 HK 1112235 A1 HK1112235 A1 HK 1112235A1 HK 08107399 A HK08107399 A HK 08107399A HK 1112235 A1 HK1112235 A1 HK 1112235A1
Authority
HK
Hong Kong
Prior art keywords
alkyl
halo
cycloalkyl
alkoxy
cor
Prior art date
Application number
HK08107399.4A
Other languages
English (en)
Inventor
Luc Lebreton
Christine Dumas
Christine Massardier
Michel Bondoux
Original Assignee
Fournier Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Lab Sa filed Critical Fournier Lab Sa
Publication of HK1112235A1 publication Critical patent/HK1112235A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK08107399.4A 2005-05-30 2008-07-04 Indoline compounds HK1112235A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0505432A FR2886293B1 (fr) 2005-05-30 2005-05-30 Nouveaux composes de l'indoline
PCT/FR2006/050487 WO2007000550A2 (fr) 2005-05-30 2006-05-29 Composes de l' indoline

Publications (1)

Publication Number Publication Date
HK1112235A1 true HK1112235A1 (en) 2008-08-29

Family

ID=35501068

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08107399.4A HK1112235A1 (en) 2005-05-30 2008-07-04 Indoline compounds

Country Status (29)

Country Link
US (1) US7465811B2 (de)
EP (1) EP1885695B8 (de)
JP (1) JP2008545736A (de)
KR (1) KR20080021609A (de)
CN (2) CN101184731A (de)
AT (1) ATE423768T1 (de)
AU (1) AU2006263745B2 (de)
BR (1) BRPI0610064A2 (de)
CA (1) CA2611128A1 (de)
CY (1) CY1109043T1 (de)
DE (1) DE602006005356D1 (de)
DK (1) DK1885695T3 (de)
EA (1) EA012971B1 (de)
ES (1) ES2322620T3 (de)
FR (1) FR2886293B1 (de)
HK (1) HK1112235A1 (de)
HR (1) HRP20090243T1 (de)
IL (1) IL187413A (de)
MA (1) MA29494B1 (de)
MX (1) MX2007015070A (de)
NO (1) NO20075841L (de)
PL (1) PL1885695T3 (de)
PT (1) PT1885695E (de)
RS (1) RS50969B (de)
SI (1) SI1885695T1 (de)
TN (1) TNSN07448A1 (de)
UA (1) UA92013C2 (de)
WO (1) WO2007000550A2 (de)
ZA (1) ZA200710258B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2869904B1 (fr) * 2004-05-07 2006-07-28 Fournier S A Sa Lab Modulateurs des recepteurs lxr
GB0526257D0 (en) 2005-12-22 2006-02-01 Novartis Ag Organic compounds
AR071375A1 (es) * 2008-04-22 2010-06-16 Solvay Pharm Gmbh Formulaciones para ingredientes farmaceuticos activos de permeabilidad deficiente, proceso de preparacion y producto
TWI748194B (zh) * 2018-06-28 2021-12-01 德商菲尼克斯 Ｆｘｒ有限責任公司 含有雙環核心部分之新穎lxr調節劑
CN114773190A (zh) * 2022-04-20 2022-07-22 江西天宇化工有限公司 一种制备2,4-二氯苯氧乙酸异辛酯的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316503B1 (en) * 1999-03-15 2001-11-13 Tularik Inc. LXR modulators
US6855708B2 (en) * 2001-03-20 2005-02-15 Merck & Co., Inc. N-arylsulfonyl aza-bicyclic derivatives as potent cell adhesion inhibitors
TW200303742A (en) * 2001-11-21 2003-09-16 Novartis Ag Organic compounds
DE10229777A1 (de) * 2002-07-03 2004-01-29 Bayer Ag Indolin-Phenylsulfonamid-Derivate
FR2869904B1 (fr) * 2004-05-07 2006-07-28 Fournier S A Sa Lab Modulateurs des recepteurs lxr

Also Published As

Publication number Publication date
PT1885695E (pt) 2009-05-20
CN101184731A (zh) 2008-05-21
PL1885695T3 (pl) 2009-10-30
MX2007015070A (es) 2008-01-24
SI1885695T1 (sl) 2009-08-31
EA200702324A1 (ru) 2008-04-28
FR2886293B1 (fr) 2007-08-24
ZA200710258B (en) 2009-10-28
DK1885695T3 (da) 2009-05-18
ATE423768T1 (de) 2009-03-15
EP1885695B8 (de) 2009-08-12
TNSN07448A1 (fr) 2009-03-17
EA012971B1 (ru) 2010-02-26
UA92013C2 (en) 2010-09-27
FR2886293A1 (fr) 2006-12-01
HRP20090243T1 (en) 2009-06-30
EP1885695B1 (de) 2009-02-25
CN102746214A (zh) 2012-10-24
US7465811B2 (en) 2008-12-16
NO20075841L (no) 2008-01-21
JP2008545736A (ja) 2008-12-18
AU2006263745B2 (en) 2012-03-15
KR20080021609A (ko) 2008-03-07
CA2611128A1 (fr) 2007-01-04
BRPI0610064A2 (pt) 2011-10-18
US20080119465A1 (en) 2008-05-22
WO2007000550A2 (fr) 2007-01-04
AU2006263745A1 (en) 2007-01-04
WO2007000550A3 (fr) 2007-02-22
ES2322620T3 (es) 2009-06-23
EP1885695A2 (de) 2008-02-13
IL187413A (en) 2011-10-31
DE602006005356D1 (de) 2009-04-09
RS50969B (sr) 2010-10-31
CY1109043T1 (el) 2014-07-02
IL187413A0 (en) 2008-02-09
MA29494B1 (fr) 2008-05-02

Similar Documents

Publication Publication Date Title
HRP20090243T1 (en) Indoline compounds
NO20056196L (no) Makrocykliske kinazolinderivater som antiproliferative midler
NO331165B1 (no) Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter
WO2005080384A3 (en) Benzimidazole derivative and use as aii receptor antagonist
HK1096663A1 (en) Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
PL1672017T3 (pl) Mieszaniny kauczukowe
AR028683A1 (es) Derivados de 1,3,8-triaza-espiro[4.5]decan-4-ona
HUP0302922A2 (hu) Sejtburjánzást gátló hatású imidazolo-5-il-2-anilino-pirimidinek és ezeket tartalmazó gyógyszerkészítmények
DE502005001916D1 (de) Substituierte oxindol-derivate und diese enthaltende arzneimittel
MXPA05006907A (es) Compuestos diazoicos cationicos, composiciones que los contienen como colorante directo, procedimiento de coloracion de fibras queratinicas y dispositivo.
MX2010009959A (es) Compuestos y metodo para reducir el acido urico.
EP1167366A4 (de) Aminderivate
TW200745033A (en) Oxindole derivative as feeding control agent
EP1798227A4 (de) Agonist des serotonin-5-ht3-rezeptors
NO984761L (no) Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler
MX2010001566A (es) Derivado de aminopirazolamida.
SE0201194D0 (sv) New compounds
ATE502936T1 (de) 2, 6-di-(hetero-)aryl-4-amido-pyrimidine als adenosin-rezeptor-antagonisten
JP2011510072A5 (de)
JP2010518016A5 (de)
WO2009027626A3 (en) Improvements in or relating to organic compounds
NO20054794L (no) 7 ([1, 4] dioksan-2-yl)-benzotiazolderivater som adenosinreseptorligander
CA2291761A1 (en) Fungicidal mixture
CA2523253A1 (en) Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists
NO20061819L (no) Ligander

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130529